Literature DB >> 24470194

LC-MS/MS analysis and comparison of oxidative damages on peptides induced by pathogen reduction technologies for platelets.

Michel Prudent1, Giona Sonego, Mélanie Abonnenc, Jean-Daniel Tissot, Niels Lion.   

Abstract

Pathogen reduction technologies (PRT) are photochemical processes that use a combination of photosensitizers and UV-light to inactivate pathogens in platelet concentrates (PCs), a blood-derived product used to prevent hemorrhage. However, different studies have questioned the impact of PRT on platelet function and transfusion efficacy, and several proteomic analyses revealed possible oxidative damages to proteins. The present work focused on the oxidative damages produced by the two main PRT on peptides. Model peptides containing residues prone to oxidation (tyrosine, histidine, tryptophane, and cysteine) were irradiated with a combination of amotosalen/UVA (Intercept process) or riboflavin/UVB (Mirasol-like process). Modifications were identified and quantified by liquid chromatography coupled to tandem mass spectrometry. Cysteine-containing peptides formed disulfide bridges (R-SS-R, -2 Da; favored following amotosalen/UVA), sulfenic and sulfonic acids (R-SOH, +16 Da, R-SO3H, +48 Da, favored following riboflavin/UVB) upon treatment and the other amino acids exhibited different oxidations revealed by mass shifts from +4 to +34 Da involving different mechanisms; no photoadducts were detected. These amino acids were not equally affected by the PRT and the combination riboflavin/UVB generated more oxidation than amotosalen/UVA. This work identifies the different types and sites of peptide oxidations under the photochemical treatments and demonstrates that the two PRT may behave differently. The potential impact on proteins and platelet functions may thus be PRT-dependent.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24470194     DOI: 10.1007/s13361-013-0813-8

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  49 in total

1.  The extent of amotosalen photodegradation during photochemical treatment of platelet components correlates with the level of pathogen inactivation.

Authors:  Weiqun Liu; George D Cimino; Laurence Corash; Lily Lin
Journal:  Transfusion       Date:  2011-01       Impact factor: 3.157

2.  Bioconversion of L-tyrosine to L-DOPA by a novel bacterium Bacillus sp. JPJ.

Authors:  Shripad N Surwase; Jyoti P Jadhav
Journal:  Amino Acids       Date:  2010-10-21       Impact factor: 3.520

3.  Oxidation of proteins: Basic principles and perspectives for blood proteomics.

Authors:  Stefano Barelli; Giorgia Canellini; Lynne Thadikkaran; David Crettaz; Manfredo Quadroni; Joël S Rossier; Jean-Daniel Tissot; Niels Lion
Journal:  Proteomics Clin Appl       Date:  2008-02       Impact factor: 3.494

4.  Using the electrochemistry of the electrospray ion source.

Authors:  Gary J Van Berkel; Vilmos Kertesz
Journal:  Anal Chem       Date:  2007-08-01       Impact factor: 6.986

5.  Evaluation of platelet transfusion clinical trials.

Authors:  Laurence Corash; Claire D Sherman
Journal:  Br J Haematol       Date:  2011-01-31       Impact factor: 6.998

6.  Isolation and partial characterization of a novel psoralen-tyrosine photoconjugate from a photoreaction of psoralen with a natural protein.

Authors:  S S Sastry
Journal:  Photochem Photobiol       Date:  1997-06       Impact factor: 3.421

7.  A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion.

Authors:  Miguel Lozano; Folke Knutson; René Tardivel; Joan Cid; Rosa Maria Maymó; Helena Löf; Huw Roddie; Jane Pelly; Anthony Docherty; Claire Sherman; Lily Lin; Meisa Propst; Laurence Corash; Chris Prowse
Journal:  Br J Haematol       Date:  2011-03-21       Impact factor: 6.998

8.  Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.

Authors:  S Perez-Pujol; R Tonda; M Lozano; B Fuste; I Lopez-Vilchez; A M Galan; J Li; R Goodrich; G Escolar
Journal:  Transfusion       Date:  2005-06       Impact factor: 3.157

9.  Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage.

Authors:  Peter Schubert; Brankica Culibrk; Danielle Coupland; Ken Scammell; Maria Gyongyossy-Issa; Dana V Devine
Journal:  Transfusion       Date:  2011-08-09       Impact factor: 3.157

10.  Separation, identification and quantification of riboflavin and its photoproducts in blood products using high-performance liquid chromatography with fluorescence detection: a method to support pathogen reduction technology.

Authors:  Christopher C Hardwick; Troy R Herivel; Shiloh C Hernandez; Patrick H Ruane; Raymond P Goodrich
Journal:  Photochem Photobiol       Date:  2004 Nov-Dec       Impact factor: 3.421

View more
  5 in total

1.  Treatment of Platelet Concentrates with the Mirasol Pathogen Inactivation System Modulates Platelet Oxidative Stress and NF-κB Activation.

Authors:  Lacey Johnson; Denese Marks
Journal:  Transfus Med Hemother       Date:  2015-05-07       Impact factor: 3.747

2.  Impact of pathogen reduction methods on immunological properties of the COVID-19 convalescent plasma.

Authors:  Alexander I Kostin; Maria N Lundgren; Andrey Y Bulanov; Elena A Ladygina; Karina S Chirkova; Alexander L Gintsburg; Denis Y Logunov; Inna V Dolzhikova; Dmitry V Shcheblyakov; Natalia V Borovkova; Mikhail A Godkov; Alexey I Bazhenov; Valeriy V Shustov; Alina S Bogdanova; Alina R Kamalova; Vladimir V Ganchin; Eugene A Dombrovskiy; Stanislav E Volkov; Nataliya E Drozdova; Sergey S Petrikov
Journal:  Vox Sang       Date:  2021-03-18       Impact factor: 2.996

Review 3.  Redox Proteomics and Platelet Activation: Understanding the Redox Proteome to Improve Platelet Quality for Transfusion.

Authors:  Giona Sonego; Mélanie Abonnenc; Jean-Daniel Tissot; Michel Prudent; Niels Lion
Journal:  Int J Mol Sci       Date:  2017-02-11       Impact factor: 5.923

4.  Proteomics of apheresis platelet supernatants during routine storage: Gender-related differences.

Authors:  Monika Dzieciatkowska; Angelo D'Alessandro; Timothy A Burke; Marguerite R Kelher; Ernest E Moore; Anirban Banerjee; Christopher C Silliman; Bernadette F West; Kirk C Hansen
Journal:  J Proteomics       Date:  2014-09-06       Impact factor: 4.044

Review 5.  Impact of different pathogen reduction technologies on the biochemistry, function, and clinical effectiveness of platelet concentrates: An updated view during a pandemic.

Authors:  Gines Escolar; Maribel Diaz-Ricart; Jeffrey McCullough
Journal:  Transfusion       Date:  2021-12-06       Impact factor: 3.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.